A Preclinical Therapeutic Study of Minibody 177Lu-DOTAGA-IAB56 Targeting αVβ6 for the Treatment of Pancreatic Cancer

Therapeutic efficacy and dosimetry for a 177-lutetium radiolabeled minibody targeting DLL3 in a preclinical model of small cell lung cancer.